Tiziana Life Sciences PLC
Records under this name other than the patents Tiziana Life Sciences PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Tiziana Life Sciences PLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 16/876,839 | ANTI-CD3 Antibody Formulations Abandoned Abandoned Mar 18, 2025 | Abandoned | Abandoned Mar 18, 2025 | |
| 16/914,703 | Formulations of Milciclib and Therapeutic Combinations of the Same for Use in the Treatment of Cancer Abandoned Abandoned Nov 18, 2023 | Abandoned | Abandoned Nov 18, 2023 | |
| 17/197,603 | Compositions of IL-6/IL-6R Antibodies and Methods of Use Thereof Abandoned Abandoned Nov 19, 2024 | Abandoned | Abandoned Nov 19, 2024 | |
| 17/290,527 | Composition and Methods of Treating Inflammatory and Autoimmune Diseases Abandoned Abandoned Nov 29, 2024 | Abandoned | Abandoned Nov 29, 2024 | |
| 17/723,098 | Subcutaneous Administration of Antibodies for the Treatment of Disease Abandoned Abandoned Sep 8, 2025 | Abandoned | Abandoned Sep 8, 2025 | |
| 17/927,460 | Compositions and Methods for Augmenting Chimeric Antigen Receptor (CAR) T Cell Therapies Abandoned Abandoned Aug 7, 2026 | Abandoned | Abandoned Aug 7, 2026 | |
| 18/002,591 | CD-3 Antibodies for the Treatment of Coronavirus Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/317,810 | Unit Dose Devices for Nasal Administration of Foralumab Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/494,411 | Formulations of Milciclib and Therapeutic Combinations of the Same for Use in the Treatment of Cancer Abandoned Abandoned Oct 26, 2026 | Abandoned | Abandoned Oct 26, 2026 | |
| 18/682,324 | Combination Therapy for the Treatment of Pan-Kras Mutated Cancers Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |